Next Article in Journal
VOCs from Exhaled Breath for the Diagnosis of Hepatocellular Carcinoma
Next Article in Special Issue
Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma
Previous Article in Journal
Clinical Characteristics of Adult Functional Constipation Patients with Rectoanal Areflexia and Their Response to Biofeedback Therapy
Previous Article in Special Issue
Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
 
 
Review
Peer-Review Record

Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests

Diagnostics 2023, 13(2), 256; https://doi.org/10.3390/diagnostics13020256
by Olivier Guillaud 1,2,3,*, Jérôme Dumortier 1,3,4, Eduardo Couchonnal-Bedoya 1,5 and Mathias Ruiz 5,6
Reviewer 1:
Reviewer 2:
Diagnostics 2023, 13(2), 256; https://doi.org/10.3390/diagnostics13020256
Submission received: 11 December 2022 / Accepted: 3 January 2023 / Published: 10 January 2023
(This article belongs to the Special Issue Recent Advances in Liver Diseases Diagnosis)

Round 1

Reviewer 1 Report

This review aimed to evaluate the non-invasive diagnostic tests available to clinicians in both Wilson and alpha1-antitrypsin deficiency diseases. The paper is well-written and highly informative to both expert and non-expert readers. I recommend to publish this paper.

Reviewer 2 Report

This is a nice overview on non-invasive tests that are commonly used in clinical practice for two diseases, Wilson's disease and alfa1-AT deficiency.

Although rare, these two conditions (especially Wilson's disease) are often prone to a delayed diagnosis. Therefore, this manuscript has merit.

I think that the Authors have provided a detailed description on strengths and pitfalls of the non-invasive tests available to date.

Moreover, Tables and Figures are informative. References are adequate.

I congratulate the Authors for this paper

Regards.

Back to TopTop